Device Trial Radar · NCT05368259
The AUDACITY Study (AllUrion Device in Adults With Clinical ObesITY)
Last checked: Nov 20, 2026Latest source record: Oct 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
May 12, 2022
Primary completion
Nov 1, 2024
Study completion Mar 1, 2025
Sponsor
- Lead sponsor
- Allurion TechnologiesNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 10, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective for this clinical study is to provide FDA with clinical evidence regarding the effectiveness and safety of the AGBS + moderate intensity lifestyle modification therapy program, indwell time of the AGBS inside the stomach, and outcomes at 48 weeks.
Conditions
- Obesity
Interventions
AGBSDevice
The AGBS is designed to promote weight loss in individuals with obesity. The AGBS includes the Allurion Balloon, which is a temporary gastric balloon that promotes weight loss in individuals with obesity. The AGBS consists of up to 2 balloons placed during a 1-year period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Responder Rate (RR) dichotomized at 5% TBWL at 48 weekTime frame: 48 weeks
- %TBWL is significantly greater than Control Group mean %TBWL at 48 weeksTime frame: 48 weeks
Locations
17 sites in 1 country. Site status is shown where the registry gives one.
HonorHealth Research Institute
Scottsdale, Arizona
Cedars-Sinai
Los Angeles, California
University of Colorado, Anschutz Health and Wellness Center
Aurora, Colorado
14 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.